Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Dec 14, 2010


Norwegian company iSentio, maker of the web-based sequence analysis software RipSeq, has a new chairman of the board and investors.

Siri Fürst has been named chairman of the board. Fürst has held managerial positions at Hafslund, Hafslund Nycomed, and Nycomed Pharma and served as CEO at DiaGenic. In 2005 she joined Considium Consulting Group. She holds a degree in economics from the Norwegian School of Economics and Business Administration.

Norwegian seed capital fund company Sarsia Seed has become a new investor and will hold two positions on iSentio's board. Sarsia Seed invests in early-phase technology companies within the energy, cleantech, and life science sectors.

Biotech company Nodality has appointed Greg Critchfield to its board of directors. Critchfield recently retired as president of Myriad Genetic Laboratories, where he launched seven diagnostics products. Prior to Myriad, he served as Quest Diagnostics' chief medical and science officer.

He holds a BS in microbiology with a minor in chemistry from Brigham Young University, an MD from the University of Utah, and an MS in biophysical sciences from the University of Minnesota.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.